Superstat Modified Collagen Hemostatic Sponge, 7.5mm x 19mm Cone, 3.0%, Part# 9015-30, 9003-30. ...

FDA Device Recall #Z-0341-2013 — Class II — October 24, 2012

Recall Summary

Recall Number Z-0341-2013
Classification Class II — Moderate risk
Date Initiated October 24, 2012
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Superstat Corp
Location Rancho Dominguez, CA
Product Type Devices
Quantity 26,422 units

Product Description

Superstat Modified Collagen Hemostatic Sponge, 7.5mm x 19mm Cone, 3.0%, Part# 9015-30, 9003-30. For use when hemostasis is desired along suture lines, in diffusely bleeding sites, in incisions, dissections, and around arterial or venous anastomoses. Indicated in oozing bleeding, either capillary or venous, in almost all types of incisions or wounds, and as an adjunct to conventional closure techniques

Reason for Recall

The recall was initiated because Superstat Corporation has confirmed that no documentation are available to verify that quarterly dose sterility audits were performed for the Superstat Modified Collagen Hemostatic Sponge.

Distribution Pattern

Worldwide Distribution - USA (nationwide) and the countries of Saudi Arabia, Thailand, Mexico, Canada, Pakistan, Israel, Greece, Serbia, Canda, Isle of Man, Nova Scotia, and Singapore.

Lot / Code Information

Lot# SSL01C, SSN04C.

Other Recalls from Superstat Corp

Recall # Classification Product Date
Z-0339-2013 Class II Superstat Modified Collagen Hemostatic Sponge, ... Oct 24, 2012
Z-0337-2013 Class II Superstat Modified Collagen Hemostatic Sponge, ... Oct 24, 2012
Z-0333-2013 Class II Superstat Modified Collagen Hemostatic Sponge, ... Oct 24, 2012
Z-0334-2013 Class II Superstat Modified Collagen Hemostatic Sponge, ... Oct 24, 2012
Z-0335-2013 Class II Superstat Modified Collagen Hemostatic Sponge, ... Oct 24, 2012

Frequently Asked Questions

Sterility recalls for medical devices vary in severity. If you have already had a procedure using a potentially non-sterile device, contact your healthcare provider immediately — you may need monitoring for signs of infection. Symptoms to watch for include fever, redness or swelling at the surgical site, unusual pain, or discharge. For devices that have not yet been used, they should be quarantined and returned to the manufacturer per the recall notice. Non-sterile implants can cause serious infections; early detection and treatment are critical.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.